Colonic tumor CEA, CSAp and MUC-1 expression following radioimmunotherapy or chemotherapy.
about
Overcoming the hypoxic barrier to radiation therapy with anaerobic bacteriaA pan inhibitor of DASH family enzymes induces immunogenic modulation and sensitizes murine and human carcinoma cells to antigen-specific cytotoxic T lymphocyte killing: implications for combination therapy with cancer vaccines.DNA damage signaling is activated during cancer progression in human colorectal carcinoma.Combination therapy with local radiofrequency ablation and systemic vaccine enhances antitumor immunity and mediates local and distal tumor regression.Defining the molecular signature of chemotherapy-mediated lung tumor phenotype modulation and increased susceptibility to T-cell killing.Combination chemotherapy and radiation of human squamous cell carcinoma of the head and neck augments CTL-mediated lysis.The use of chelated radionuclide (samarium-153-ethylenediaminetetramethylenephosphonate) to modulate phenotype of tumor cells and enhance T cell-mediated killingAntitumor efficacy of colon-specific HPMA copolymer/9-aminocamptothecin conjugates in mice bearing human-colon carcinoma xenograftsWhat makes MUC1 a tumor antigen?In the field: exploiting the untapped potential of immunogenic modulation by radiation in combination with immunotherapy for the treatment of cancer.Tumour escape mechanisms and their therapeutic implications in combination tumour therapy.What role do mucins have in the development of laryngeal squamous cell carcinoma? A systematic review.Long-term clinical impact of PSA surge in castration-resistant prostate cancer patients treated with abiraterone.Modulating Both Tumor Cell Death and Innate Immunity Is Essential for Improving Radiation Therapy Effectiveness.Turning T cells on: epigenetically enhanced expression of effector T-cell costimulatory molecules on irradiated human tumor cells.Enhancing the specificity of T-cell cultures for adoptive immunotherapy of cancer.The impact of carcinoembryonic antigen flare in patients with advanced colorectal cancer receiving first-line chemotherapy.
P2860
Q24569648-B977DE8E-BFE4-48EC-9668-6FD9E2DE5E7DQ33760877-101C2272-5BCF-4FBD-927A-2A7DD851B887Q34296170-D37AF057-5477-4D2B-82C3-6403C6F62992Q34876404-11406715-3580-45BB-9DC6-7A7019140C1DQ35752182-5A21B4A6-745E-4361-8E13-EB5BE9C47E41Q35781889-1B2C5A75-A19A-4C6B-B2AE-8ED0EA6EBDD1Q36126003-3143D7CA-7815-4625-90BB-094CB048C291Q36185395-6D143685-532F-44A0-B184-FBD776C7EA5AQ36188575-40B0DEDE-96B7-4FF8-A1D5-B6996107B50AQ36210670-5BBD5939-A588-4A4A-99DC-A842CDE4ABEFQ37729243-7FBE7CE2-458B-42EC-9835-0864E81D8F7BQ37869823-E7AFA469-B4F4-4FD2-9AA1-4746FCD3BE7DQ38827364-CA1F6EBC-739B-4E48-838A-7F3DDEA6EB73Q39365749-52B1C074-E041-4722-8DF3-D6FEF04D1003Q39575992-0AE1F62F-1BC0-4052-8CFC-AB13013A7FB4Q39617589-249EA547-716C-4CCB-890C-64ED7DE08E78Q43253820-3F4FA360-67AC-4795-B048-9CA70624BA03
P2860
Colonic tumor CEA, CSAp and MUC-1 expression following radioimmunotherapy or chemotherapy.
description
2003 nî lūn-bûn
@nan
2003年の論文
@ja
2003年学术文章
@wuu
2003年学术文章
@zh
2003年学术文章
@zh-cn
2003年学术文章
@zh-hans
2003年学术文章
@zh-my
2003年学术文章
@zh-sg
2003年學術文章
@yue
2003年學術文章
@zh-hant
name
Colonic tumor CEA, CSAp and MU ...... immunotherapy or chemotherapy.
@en
Colonic tumor CEA, CSAp and MU ...... immunotherapy or chemotherapy.
@nl
type
label
Colonic tumor CEA, CSAp and MU ...... immunotherapy or chemotherapy.
@en
Colonic tumor CEA, CSAp and MU ...... immunotherapy or chemotherapy.
@nl
prefLabel
Colonic tumor CEA, CSAp and MU ...... immunotherapy or chemotherapy.
@en
Colonic tumor CEA, CSAp and MU ...... immunotherapy or chemotherapy.
@nl
P2093
P356
P1433
P1476
Colonic tumor CEA, CSAp and MU ...... immunotherapy or chemotherapy.
@en
P2093
D E Modrak
D M Goldenberg
R D Blumenthal
P2888
P356
10.1159/000070658
P577
2003-01-01T00:00:00Z
P6179
1012030646